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Integrin transmembrane receptors control a wide range of biological interactions by triggering the 
assembly of large multiprotein complexes at their cytoplasmic interface. Diverse methods have been 
used to investigate interactions between integrins and intracellular proteins, and predominantly include 
peptide-based pull-downs and biochemical immuno-isolations from detergent-solubilized cell lysates. 
However, quantitative methods to probe integrin-protein-protein interactions in a more biologically 
relevant context where the integrin is embedded within a lipid bilayer have been lacking. Here we 
describe ProLIF (Protein-Liposome Interactions by Flow cytometry), a technique to reconstitute 
recombinant integrin transmembrane domain (TMD) and cytoplasmic tail (CT) fragments in liposomes 
as individual subunits or DVĮȕ heterodimers and, using flow cytometry, to rapidly and quantitatively 
measure protein interactions with these membrane-embedded integrins. Importantly, the assay can 
analyse binding of fluorescent proteins directly from cell lysates without further purification steps. 
Moreover, the effect of membrane composition, such as PI(4,5)P2 incorporation, on protein recruitment 
to the integrin CTs can be analysed. ProLIF requires no specific instrumentation and can be applied to 
measure a broad range of membrane-dependent protein-protein interactions with the potential for high-
throughput/multiplex analyses. 
Introduction 
Lipids provide an essential platform for protein interactions and biochemical reactions at biological 
membranes. Many techniques are available to assess protein-lipid binding and phosphoinositide (PI) 
specificity (Zhao and Lappalainen, 2012). Many of these assays and in particular those based on 
liposome generation - currently considered more representative of the in cellulo situation - need 
specialized equipment or employ complex protocols (e.g. surface plasmon resonance, isothermal 
titration calorimetry and lipid microarray) (Ananthanarayanan et al., 2003; Besenicar et al., 2006; 
Lemmon et al., 1995; Saliba et al., 2014; Wu et al., 2012) that restrict their usage to specialized 
laboratories. Furthermore these approaches require high lipid/protein concentrations that prevent large 
and systematic analyses and/or remain merely qualitative. Recently, several microscopy-based methods 
have been developed (Ceccato et al., 2016; Saliba et al., 2014) that provide quantitative data on protein 
interactions with liposomes and have the potential for high-throughput analyses. Flow cytometry has 
also been employed to quantify binding of purified recombinant proteins to liposomes (Temmerman 
and Nickel, 2009). However, none of these methodologies have been designed to incorporate 
transmembrane proteins within the lipid bilayer. 
 
It is estimated that transmembrane proteins constitute up to one third of the human proteome (Ahram 
et al., 2006; Almen et al., 2009) and are essential components of biological membranes, constituting 

































   
 
 
plethora of essential cellular events, ranging from signal transduction to the flux of ions and metabolites 
across the membrane in response to a changing microenvironment. Due to their functions and 
accessibility, they represent more than 60% of drug targets (Arinaminpathy et al., 2009). In spite of 
their importance, versatile methodologies to explore protein-protein interactions of transmembrane 
proteins within an experimentally controlled lipid microenvironment remain underdeveloped.  
 
Integrins, an essential family of heterodimeric transmembrane adhesion receptors, recruit and support 
the formation of cytoplasmic protein complexes, collectively known as the integrin adhesome, at the 
plasma membrane to generate the cell machinery responsible for cell adhesion and adhesion-induced 
signalling and migration (Winograd-Katz et al., 2014). Currently, molecular interactions between 
integrin and adhesome components are mainly studied by qualitative techniques such as pull-downs 
using synthetic peptides or soluble recombinant proteins mimicking the integrin cytoplasmic domains. 
Alternatively, endogenous integrins are immunoprecipitated in the presence of detergents. In all these 
approaches, an intact membrane is absent, even though several core adhesome proteins, such as talin, 
are known to bind acidic phospholipids. As a result, investigations into the joint requirement of integrin 
TMD-CT domains and acidic phospholipids in mediating protein recruitment to integrin tails have been, 
thus far, largely neglected. 
 
Here, we describe a simple, sensitive and quantitative technique called ProLIF (Protein-Liposome 
Interactions by Flow cytometry) to simultaneously detect and quantify protein-protein and protein-lipid 
interactions in reconstituted proteoliposomes. We reconstituted "artificial integrins" into 
proteoliposomes and investigated talin binding, as it is the most studied protein interacting with both 
the integrin cytoplasmic tail and the plasma membrane in a phosphatidylinositol phosphate (PIP)-
dependent manner (Calderwood et al., 2013). We used this interaction to demonstrate the applicability 
of our method for probing integrin-cytoplasmic protein interactions in the context of a lipid bilayer of 
defined composition. We optimized ProLIF towards a mammalian expression system to circumvent the 
requirement for protein purification, preserve post-translational modifications, and to enable the 
presence of possible essential co-factors to provide a more realistic biological characterization of 




Generation of streptavidin-bead coupled liposomes for FACS detection 
We first tested ProLIF by analysing the coupling of bare liposomes, containing a small fraction of 
biotinylated-lipids, to streptavidin-coated carrier beads, according to steps 1, 3 and 4 outlined in the 

































   
 
 
detergent removal by gradual addition of Bio-BeadsTM (Rigaud et al., 1995). Although bare liposomes 
can also be produced using extrusion, giving control over the size of the resulting small unilamellar 
vesicles (SUVs) (Temmerman and Nickel, 2009), this technique does not allow for incorporation of 
transmembrane proteins. In contrast, detergent removal by Bio-BeadsTM is a robust method that has 
been used to reconstitute many functional transmembrane proteins (Geertsma et al., 2008; Kolena, 
1989; Lacapère et al., 2001; Moriyama et al., 1984; Mouro-Chanteloup et al., 2010; Nesper et al., 2008; 
Neves et al., 2009; Richard et al., 1990; Smith and Morrissey, 2004; Young et al., 1997) resulting in 
unilamellar vesicles (Rigaud et al., 1995). Such vesicles are close to the detection limit of the scatter of 
laser light in FACS instruments (Temmerman and Nickel, 2009). In order to make these liposomes 
amenable to standard flow cytometry detection, we incorporated biotinylated lipids (2% of total lipid 
content) during liposome preparation to enable vesicle capture on Streptavidin Sepharose beads (SA)-
beads that have an average diameter of 34 µm. The SA-beads are easily detected in a flow cytometer 
using forward scatter (FSC) and side scatter (SSC) plots (Fig.S1a). Upon addition of biotinylated 
liposomes, a distinct population of small objects appears (Fig.S1b); however, this population was gated 
out during the analysis. Importantly, addition of biotinylated liposomes did not appear to promote bead 
aggregation, as the FSC-A (Forward scatter area)/FSC-W (Forward scatter width) plot demonstrated a 
single population. To confirm that liposomes were captured by the SA-beads, we produced liposomes 
encapsulating Cy5 dye (Fig. 1b). A strong signal was detected by flow cytometry when the Cy5-
encapsulated liposomes were captured on SA-beads. Importantly, interactions between SA-beads and 
Cy5-encapsulated biotinylated-liposomes could be effectively outcompeted by the addition of soluble 
biotin (Fig.1b), confirming specific biotin-mediated binding of liposomes to the carrier beads.  
 
Optimal detection of lipid interactions with proteins isolated from mammalian cell lysates 
Protein purification can be time consuming and depending on the protein production source, critical 
post-translational modifications regulating protein binding to cell membrane components may be 
lacking. To overcome this limitation we tested the suitability of ProLIF to detect membrane interactions 
of phosphatidylinositide (PI)-binding proteins generated in human embryonic kidney cells (HEK293 
cell line). Cells expressing EGFP-tagged PI-binding domains, known to interact with specific PIPs in 
membranes, were lysed in a detergent-free extraction buffer and fractions enriched in cytoplasmic 
proteins and devoid of transmembrane and membrane-associated molecules were isolated by 
ultracentrifugation (Fig.S1c). To overcome experimental variability due to changes in protein 
expression levels and to allow comparison between different experimental conditions, the fluorescence 
intensity of the cytoplasmic fractions were measured in relation to an external fluorescein standard and 
equalized before the binding assay. 
Detergent-free cell lysates were subsequently incubated with liposomes followed by SA-beads and then 
liposome-bound SA-beads were analysed by flow cytometry, according to the steps indicated in Fig.1a. 

































   
 
 
conditions were kept constant for all samples. Beads were gated based on forward and side scattering 
and fluorescence intensity of the gated population was visualized using a histogram (fluorescence 
intensity vs. particle count) (Fig.1c,d).  
 
SA-beads have a detectable level of auto-fluorescence (Fig.1c), thus in each experiment a sample 
containing beads only was also included and the auto-fluorescence was subtracted from all samples. 
Thus, the specific fluorescence signal corresponding to EGFP-protein-bound liposomes was obtained. 
To determine the conditions providing the best signal to noise ratio, decreasing amounts of the 
phospholipase C-delta 1 (3/&į) pleckstrin homology (PH) domain (PLC-PH-EGFP), which binds 
preferentially to PI(4,5)P2 (Lemmon and Ferguson, 2000) were incubated with a constant amount of 
bare biotin-liposomes or PI(4,5)P2-containing biotin-liposomes, captured on SA-beads and analysed by 
flow cytometry. The resulting titration data indicated that a concentration close to 8 nM provided a good 
compromise between achieving optimal signal/noise ratio and minimizing the amount of biological 
material needed for the experiment (Fig.S1d, see below the equation for calculating the protein 
concentration).  
 
Detecting specific protein-lipid interactions 
Having established optimal experimental conditions to detect binding of fluorescently tagged proteins 
to liposomes, we next investigated whether ProLIF could be used to detect well-documented protein-
lipid interactions in a reproducible manner. PH domains are broadly expressed in numerous cytoplasmic 
signalling proteins and are known to promote protein binding to specific lipids in the membrane. We 
first compared binding of EGFP alone or EGFP-tagged Bruton Tyrosine Kinase (BTK) PH domain 
(BTK-PH-EGFP) to various liposomes. Beads alone were used as a control for autofluorescence (as 
described above). In addition, bare liposomes (no PI) were compared to liposomes containing 2.5% 
PI(4,5)P2 or PI(3,4,5)P3. As shown in Fig.1d,e; and S2a, binding of EGFP alone demonstrated 
background level binding with the signal intensity remaining similar in all liposome conditions. In 
contrast, BTK-PH-EGFP bound efficiently to PI(3,4,5)P3 liposomes, whereas binding to PI(4,5)P2 was 
very low, in line with the previously reported PI specificity for this PH-domain (Kojima et al., 1997; 
Rameh et al., 1997). 
To explore the specificity of ProLIF further, we analyzed binding of two additional biologically distinct 
lipid-binding domains to liposomes. The PLCG 1 PH-domain binds to PI(4,5)P2 serving as a specific 
tether that guides the protein to the plasma membrane (Garcia et al., 1995). In contrast, the zinc-finger 
FYVE-domain, found in proteins such as the early endosomal antigen 1 (EEA1), binds 
phosphatidylinositol 3-phosphate (PI(3)P) specifically enriched on endosomal membranes, and 
fluorescently tagged fusions of tandem FYVE-domains (2xFYVE) serve as faithful reporters of PI(3)P 
enriched membranes in cells (Gillooly et al., 2000; Stenmark et al., 2002). Importantly, the PI specificity 

































   
 
 
binding specifically to liposomes containing 2.5% PI(4,5)P2 (Fig. 1f, S2b) and strong binding of a 
tandem FYVE zinc finger domain to PI(3)P (Fig.1g).  
 
Quantitative analyses of protein-lipid interactions 
To take the system a step further towards quantitative measurement of protein-lipid interactions we first 
devised a way to calculate the concentrations of the EGFP-tagged proteins in the input mammalian cell 
lysates by using an external fluorescein standard. Based on the measured lysate fluorescence, a 
mathematical equation (equation (1); eq.1) was derived (see methods) to calculate EGFP-tagged protein 
concentration as follows: 
 ܿீி௉ ൌ ீܨ ி௉ߝா௫௧ܿா௫௧߶ா௫௧ߝீி௉߶ீி௉ܨா௫௧  
Where CExt and CGFP are the concentrations of external standard (fluorescein) and the EGFP-tagged 
protein, ѰExt and ѰGFP are the quantum yields of external standard and the EGFP-tagged protein and İExt 
and İGFP are the extinction coefficients of external standard and the EGFP-tagged protein, respectively. 
To validate this equation, the fluorescence of a recombinant GFP protein of known concentration was 
measured at serial dilutions and a standard curve was generated. These experimentally derived 
fluorescence values were inputted into equation (1), together with variables and extinction coefficients 
from the fluorescein standard curve, and GFP concentrations were reverse calculated. Using this 
approach, a GFP standard curve closely matching the original experimental data was reproduced 
(Fig.2a). Mathematically derived standard curves for EGFP-tagged proteins were generated using 
predicted extinction coefficients (see methods) and quantum yields, and the fluorescence intensity of 
cell lysates expressing EGFP-tagged proteins of interest. Taking advantage of the calculated standard 
curve for the BTK-PH-EGFP, we incubated predetermined increasing concentrations of BTK-PH-
EGFP with liposomes containing 2.5% PI(3,4,5)P3. As expected, and as demonstrated earlier with a 
similar approach for a recombinant protein (Temmerman and Nickel, 2009), saturation of binding was 
achieved with increasing protein concentrations. Based on these data we calculated a KD of 174 nM ± 
15.2 (R^2 = 0.95) for BTK-PH-EGFP binding to PI(3,4,5)P3 (Fig.2b), which is within range of 
previously reported values (Kojima et al., 1997; Rameh et al., 1997). We performed similar experiments 
for tandem FYVE domain binding to liposomes containing 2.5% PI(3)P and obtained a KD of 33.3 nM 
(R^2 = 0.81) (Fig.2c), compared to the reported KD of 50 nM for a single FYVE domain (Gillooly et al., 
2000; Gaullier et al., 2000). However, while ProLIF is extremely sensitive and can detect protein-lipid 
interactions at low protein concentrations, we found that unlike approaches that use recombinant 
proteins (Temmerman and Nickel, 2009), the amount of GFP-fused protein (e.g. PLC-PH-EGFP) 
extracted from mammalian cell lysates in our approach, is not always sufficient for determining KD 


































   
 
 
quantitative analysis of biologically distinct protein-lipid interactions of proteins isolated from 
mammalian cell lysates. 
 
Reconstituting integrin transmembrane-cytoplasmic domains on liposomes 
To apply ProLIF to study transmembrane protein interactions, we chose integrins as model proteins. 
Integrin purification requires complex protocols that are not easy to scale up, precluding high-
throughput application. For this reason, most of the studies involving purified full-length integrin are 
UHVWULFWHG WR Į,,Eȕ given the availability of platelets as a raw source. However, different integrin 
heterodimers can differ significantly in terms of physiological function and composition of their 
interactome (Rossier et al., 2012). In order to overcome this limitation, we designed two artificial genes 
encoding the TMD and CT RIWKHH[WUDFHOOXODUUHFHSWRUVĮDQGȕintegrins and fused these to enhanced 
N-terminal Jun and Fos heterodimerization modules (cJun[R]±FosW[E]) (Worrall and Mason, 2011), 
respectively (Fig.3D WR SURPRWH Į DQG ȕ LQWHJULQ pairing (integrins exist as heterodimers on the 
plasma membrane) in the same orientation. Such modular organization allows the study of different 
integrin heterodimers by simply modifying the TMD and cytoplasmic domains. Both Jun-ĮDQG)RV-
ȕLQWHJULQFKimeras could be purified from membrane fractions when expressed in E. coli by taking 
advantage of their purification tags, maltose binding protein (MBP) and glutathione S-transferase 
(GST), respectively (Fig.S3a,b). When analysed by SDS-PAGE, both Jun-Į0:N'DDQG)RV-
ȕ 0:  N'D protein bands, UHFRJQL]HG E\ VSHFLILF DQWLERGLHV UDLVHG DJDLQVW WKH Į DQG ȕ
integrin cytoplasmic domains, appeared at the correct size (Fig.3b). Moreover, Jun-Į DQG )RV-ȕ
integrins were able to heterodimerize as demonstrated by reciprocal co-immunoprecipitation (co-IP) 
DVVD\VZLWKDQWLERGLHVDJDLQVWHLWKHUWKHĮRUȕLQWegrin cytoplasmic domains (Fig.3b,c).  
Next, we reconstituted the Jun-ĮDQGRU)RV-ȕLQWHJULQFKLPHUDVLQOLSRVRPHV using the same protocol 
described above. The purified proteins, solubilized in mild detergent (see methods), were added to the 
Triton X-100 solubilized lipids, and incorporated into the lipid bilayer during detergent removal by Bio-
BeadV)LJG). In this system, we lack the means to restrict the orientation of the fusion proteins on 
the liposomes resulting in approximately 50% of the reconstituted proteins having their cytoplasmic 
tails facing outwards. Given the strong affinity of the Jun-Fos dimer, in heterodimer-containing 
liposomes both Į- and ȕ-integrin tails are also expected to face the same way resulting in 50% of dimers 
having the correct orientation. To verify whether the purified proteins were indeed being incorporated 
into liposomes, we performed a sucrose gradient flotation assay. In the presence of liposomes, the 
integrin chimeras, as single entities or as components of a heterodimer, were retrieved from the upper 
sucrose fractions indicating association between the integrin proteins and the lipid bilayer (Fig.3e). In 
contrast, in the absence of lipids, protein aggregation was observed, and Fos-ȕZDVSUHVHQW LQ WKH
lowest fraction (Fig.3e). Importantly, by using the Bio-Bead reconstitution method all protein is 
incorporated into liposomes, which makes a subsequent purification step unnecessary and helps to 





































Integrin ɴ1-cytoplasmic tail and PIPs synergize to recruit talin-head to liposomes 
The integrin cytoplasmic domains have no enzymatic activity and function by recruiting, and binding 
to, cytoplasmic adaptors and signalling proteins that link the receptor to the actin cytoskeleton (Bouvard 
et al., 2013). Talin is a classical integrin activator and one of the first proteins recruited to integrin 
KHWHURGLPHUVDWWKHSODVPDPHPEUDQH7KHWDOLQ)(50GRPDLQELQGVGLUHFWO\WRȕLQWHJULQVXEXQLWVDQ
event that is linked to VHSDUDWLRQRIWKHĮ- and ȕ-integrin tails and the subsequent activated conformation 
of the receptor and recruitment of other proteins. Talin also contains a PI binding surface within its 
FERM domain (Elliott et al., 2010) and as such offers an excellent candidate for validating the ProLIF 
system. Using a concentration of EGFP-tagged talin FERM domain (3 nM) that was determined to 
provide a good signal/noise ratio (Fig.S3c), we observed significant talin binding to liposomes 
containing the Fos-ȕ LQWHJULQ SURtein (Fig.4a,b). As expected, talin did not bind to liposomes 
containing the Jun-Į LQWHJULQ VXEXQLW DORQH. Importantly, none of the conditions caused bead 
aggregation, as only a single main population was apparent in the FSC-A/FSC-W plots (Fig.S4a). 
Interestingly, talin binding to the Fos-ȕLQWHJULQSURWHLQZDVFRPSOHWHO\ORVWZKHQWKHȕ-integrin tail 
was embedded as part of the integrin heterodimer (Jun-Į-Fos-ȕ ZLWKLQ WKH OLSRVRPH )LJ4b), 
VXJJHVWLQJWKDWWKLVFRQVWUXFWPD\UHSUHVHQWD³WDLOV-tRJHWKHU´FRQIRUPDWLRQRIWKHLQWHJULQF\WRSODVPLF
face. This inhibitory effect was not due to membrane overcrowding, as reducing the transmembrane 
protein:lipid molar ratio by 50% (1:7000 instead of 1:3500) preserved the binding pattern (Fig.S4b). 
Talin FERM interaction with liposomes was modestly, but significantly, increased when PI(4,5)P2 was 
included in the liposomes, in line with the affinity of the talin FERM domain for plasma membrane 
acidic phospholipids (Calderwood et al., 2013). Notably, the presence of PI(4,5)P2 and Fos-ȕLQWHJULQ
in the same liposomes substantially enhanced talin binding far beyond levels observed for each 
individual component, suggesting an additive and possibly synergistic binding effect, revealed by the 
ability of the ProLIF system to incorporate membrane-embedded integrins and membrane lipids in the 
same binding assay. In PI(4,5)P2 containing vesicles, talin FERM binding was reduced when both Fos-
ȕ1 and Jun-Į were present (Fig.4b). Binding of talin FERM domain to Jun-Į DQG 3,32 was 
similar to conditions containing PI(4,5)P2 alone, suggesting that the talin FERM-PI(4,5)P2 interaction 
is preserved despite loss of interaction with the ȕ1-integrin receptor (Fig.4b). Incubation with an excess 
of soluble biotin, which outcompetes liposome binding to the beads, resulted in the complete loss of the 
fluorescence signal (Fig.S4c), serving as an important control and confirming that the signal is only due 
to binding events occurring at the membrane rather than unspecific binding to the beads. 
 
With ProLIF, we could also observe talin binding to PI(3,4,5)P3 alone and detected a substantial 
enhancement in talin binding to PI(3,4,5)P3 and Fos-ȕ LQWHJULQ-containing liposomes that was 
equivalent to PI(4,5)P2 and Fos-ȕLQWHJULQ-containing liposomes (Fig.4c,d). The ability of talin to tether 

































   
 
 
carefully studied before and may be linked to interesting biological functions warranting further 
investigation in the future. 
 
Next, we set out to determine the KD for talin FERM binding to integrins in our system but were unable 
to isolate enough of the protein from mammalian cell lysates to perform the experiment. However, we 
took advantage of ProLIF as a versatile system that can be tailored towards recombinant proteins, to 
monitor binding of a recombinant His-tagged talin FERM protein to ɴ1-integrin-containing liposomes 
in vitro. Using this approach, we were able to determine a KD of 0.77 µM (R^2 = 0.65) for talin FERM 
(Fig. 4e). ȕ-integrin peptides binding to talin head fragments in solution have been reported by multiple 
groups to be significantly weaker (i.e. KD 0IRUȕ$ELQGLQJWR7DOLQ)$QWKLVHWDO
demonstrating the central role of the membrane in mediating these interactions, and illustrating why 




We demonstrate here that ProLIF is a sensitive, versatile and quantitative system to study protein 
interactions at the cytoplasmic interface of transmembrane proteins, taking into account the individual 
or synergistic contribution of protein-protein and protein-membrane lipid interactions. 
The benefits and sensitivity of ProLIF are particularly exemplified with the integrin chimeras. Many 
individual protein-protein interactions in the integrin adhesome are characteristically of low affinity and 
much of the biology is based on synergistic binding events, clustering and multivalent interactions. 
Thus, studying the integrin cytoplasmic interactions with biochemical assays such as pull-downs with 
integrin-tail peptides in detergent can be challenging and do not represent the situation in cells. This is 
highlighted by the ProLIF data, which demonstrates that the talin-ȕ LQWHJULQ LQWHUDFWLRQ LVVWURQJO\
enhanced by the presence of specific PI species. Thus, it is important to investigate how protein-protein 
interactions are regulated in the context of changing membrane lipid composition, an aspect that is 
potentially underestimated in the current integrin cell adhesion literature. Indeed, a number of lipid-
binding domains have been identified and characterized (Lemmon, 2008) and the domain architecture 
of many proteins, including trafficking proteins, kinases and scaffold proteins, combines lipid- and 
protein-binding modules (Cullen, 2008; Pearce et al., 2010). Thus, the synergistic effect observed for 
talin is likely to be a widespread phenomenon that could be addressed using ProLIF. 
The mammalian expression system, optimized for ProLIF, also adds novelty over other methods 
available for monitoring protein-lipid binding as it supports posttranslational modifications of the 
soluble protein and the formation of protein complexes within cells. These events could be manipulated 
by biological reagents to gain further insight into mechanisms regulating protein binding to membrane 

































   
 
 
We believe that the simple strategy for lipid and protein reconstitution in liposomes and the use of a 
flow cytometer makes ProLIF a powerful, yet amenable tool for the quantitative detection of binding 
events on membranes, which can be applied to other transmembrane proteins. Moreover, ProLIF can 





Plasmids and constructs. The Jun-ĮLQWHJULQDUWLILFLDOJHQH(human alpha 5 amino acids 989-1049) 
was synthesized by DNA2.0 in pD441-HMBP. The Fos-ȕLQWHJULQ(human beta 1 amino acids 725 to 
798) artificial gene was synthesized by DNA2.0 and cloned in the pGEX-4T vector using EcoRI and 
BamHI cloning sites. Glycine linkers were inserted between the Jun/Fos dimerization motifs and the 
integrin transmembrane domains. Insertion of the 6 x His Tag was performed by QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technologies). All constructs were fully sequenced prior to use. 
 


















Plasmids encoding BTK-PH-EGFP and 3/&į-PH-EGFP were kind gifts from Matthias Wymann 
(University of Basel, Switzerland). The EGFP-tagged tandem FYVE was a gift from Harald Stenmark 

































   
 
 
EGFP (mouse talin1 residues 1-433) construct was made by the PROTEX facility at the University of 
Leicester, UK. The recombinant His-tagged talin FERM (mouse talin1 residues 1-405) has been 
described previously (Elliott et al., 2010). 
Cells, antibodies, lipids and reagents. HEK 293 cells ($7&&ZHUHJURZQLQ'XOEHFFR¶VPRGLILHG
(DJOH¶VPHGLXP'0(0ZLWKKLJKJOXFRVHPJPO6LJPD-Aldrich) supplemented with 1% L-
glutamine (Gibco), 10% foetal bovine serum (FBS; Sigma-Aldrich), and 1% penicillin-streptomycin 
(Sigma-Aldrich). HEK 293 cells were tested for mycoplasma contamination prior to use. The following 
antibodies were used: anti-LQWHJULQ ȕ $EFDP; Ab183666) and anti-LQWHJULQ Į Merck Millipore; 
AB1949) for immunoblotting and immunoprecipitation. The following lipids were used: L-Į-
phosphatidylcholine (EggPC, 840051P); L-Į-phosphatidic acid (EggPA, 840101P); 5-cholestene-
ĮĮ-GLRO Į-hydroxycholesterol, 700156); L-Į-phosphatidylinositol-4,5-bisphosphate (Brain 
PI(4,5)P2, 840046X); 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-
trisphosphate) (18:0-20:4 PI(3,4,5)P3, 850166P); 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-
3'-phosphate) (18:1 PI(3)P, 850150P); 1-oleoyl-2-(12-biotinyl(aminododecanoyl))-sn-glycero-3-
phosphoethanolamine (18:1-12:0 Biotin PE, 860562P). All lipids were purchased from Avanti Polar 
Lipids. Recombinant GFP protein was purchased from Thermo Fischer Scientific. Streptavidin 
Sepharose High Performance beads (17-5113-01) were purchased from GE Healthcare. 
Membrane protein purification. The Rosetta strain (Merck) of competent cells was used for Jun- Į
and Fos- ȕSURWHLQH[SUHVVLRQ%ULHIO\EDFWHULDZHUHWUDQVIRUPHGZLWKWKHUHVSHFWLYH'1$DFFRUGLQJ
WRPDQXIDFWXUHU¶VLQVWUXFWLRQVDQGSRVLWLYHFORQHVZHUHVHOHFWHGRQDJDUSODWHVFRQWDLQLQJȝJPO
DPSLFLOOLQDQGȝJPOFKORUDPSKHQLFROERWKIURP6LJPD. Transformed bacteria were then grown in 
LB broth containing ampicillin and chloramphenicol until OD600 = 0.6 at which point protein 
expression was induced by addition of 0.5 mM IPTG (Sigma) for 5 hr at 25oC. Bacteria were pelleted, 
transferred to a falcon tube and flash-frozen in liquid N2. Cells were resuspended in 50 mM Tris pH 
7.5, 150 mM NaCl, 600 µM TCEP (Tris(2-carboxyethyl)phosphine hydrochloride, Sigma), 500 µM 
PMSF (Sigma), 2 mM AEBSF (4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride, Sigma), 0.1 
mg/ml DNase (Roche), protease inhibitor (Roche), 1 mM mercaptoethanol (Sigma), 5 mM MgCl2 and 
lysozyme (Sigma) and disrupted using a cell disruptor. Cell lysates were clarified at 15000 rpm using a 
JA 25/50 rotor for 20 min at +4oC and resulting supernatants further centrifuged at 48000 rpm in a 
Ti50.2 rotor for 1 hr to pellet membranes. The membrane pellet was resuspended in 50 mM Tris pH 
7.5, 150 mM NaCl, 600 µM TCEP, 500 µM PMSF, 1 mM AEBSF and homogenized in a Teflon 
homogenizer and after addition of sucrose (300 mM) samples were flash-frozen in liquid N2. Membrane 
suspensions were thawed, incubated with n-Dodecyl-ȕ-D-Maltoside (DDM) (Anatrace) at a 5:1 (w:w) 
ratio for 2 hr at +4oC with agitation and centrifuged at 45000 rpm in a Ti50.2 rotor for 50 min at +4oC. 
Supernatants were incubated with Ni2+ sepharose beads (GE healthcare) for 2 hr at +4oC. Beads were 

































   
 
 
by a second wash with 50 mM Tris pH 7.5, 150 mM NaCl, 600 µM TCEP, 1mM AEBSF and either 
0.05% DDM (for Fos-ȕRU''0IRU-XQ-Į3URWHLQVZHUHHOXWHGZLWKP07ULVS+ 7.5, 
150 mM NaCl, 1mM AEBSF, 0.05% DDM + 250 mM imidazole. Eluted proteins were incubated with 
either glutathione Sepharose beads (purification of GST-tagged Fos-b1; GE Healthcare) or dextrin 
sepharose beads (purification of MBP-tagged Jun-a5; GE Healthcare) for 60 min at +4oC. Beads were 
washed with 50 mM Tris pH 7.5, 150 mM NaCl, 600 µM TCEP, 1 mM AEBSF and either 0.05% DDM 
(for Fos-ȕRU''0IRU-XQ-Į3URWHLQVZHUHHOXWHGZLWKP07ULVS+P01D&O
1 mM AEBSF, 0.05% DDM and either 30 mM glutathione (for Fos-ȕRUP0PDOWRVHIRU-XQ-Į
and flash frozen in 10% glycerol in liquid N2 and stored at -80oC. Approximately 1 mg of protein/L of 
bacterial culture was purified using this technique. 
Bio-BeadsTM preparation and dosing. Bio-BeadsTM (Bio-Rad) were sifted to exclude small beads and 
subsequently washed three times with methanol and five times with dH2O. Beads were left to sediment 
and during liposome preparation (see below) added in volumes of 15 µl (reproducibly corresponds to 3 
mg of beads), collected from the bottom of the tube using a cut tip.  
Liposome and proteoliposome reconstitution. The control lipid mix used throughout the study, unless 
otherwise indicated, was composed of 73% (w/w) Egg-PC, 10% (w/w) Egg-PA, 15% (w/w) cholesterol 
and 2% (w/w) biotinylated-lipids. Where indicated PIs were included at the expense of Egg-PA to 
preserve the percentage of negatively charged lipids at 10%.  
In the case of BTK-PH-EGFP KD fitting and BTK-PH-EGFP example histograms in Fig. 1d the 
liposome composition used was 80.5% (w/w) POPC (synthetic substitute for Egg-PC; 850457P, Avanti 
Polar Lipids) lipids, 15% (w/w) cholesterol and 2% (w/w) biotinylated lipids + 2.5% (w/w) PI(3,4,5)P3. 
The lipids solubilized in organic solvent were mixed and dried under a N2 stream, vacuum-dried for at 
least 20 min, resuspended in dH2O at 10 mg/ml and vortexed. The resulting liposomes were aliquoted 
in single-use aliquots and stored at -20oC. For each liposome/proteoliposome reconstitution, 400 µg of 
total lipids were solubilized in Triton X-100 (Triton X-100:lipid ratio of 2.5 w/w) in a total volume of 
400 µl of reconstitution buffer (50 mM Tris pH 7.0, 150 mM NaCl and 600 µM TCEP) at RT with 
constant stirring until the solution became clear indicating total lipid solubilisation. Solubilized lipids 
were cooled to +4°C and 1 mM EDTA, 5 mM AEBSF, GST-Fos-ȕDQG/or  MBP-Jun-ĮZere added 
to the solution and stirred at +4°C for 15 min. Prewashed Bio-BeadsTM (total 48 mg) were gradually 
added to the solution at +4°C while constantly stirring: 3 mg of Bio-Beads were added and the solution 
was  incubated for 90 min, followed by 3 mg of Bio-Beads and 90 min incubation, followed by 12 mg 


































   
 
 
Cell transfection. HEK 293 cells were seeded at a density of 25-35% confluence and transfected the 
next day at 50-70% confluence according to the following protocol for a 10 cm dish. The plasmid of 
interest (12 µg) was mixed with 250 µl of Opti-MEM (Gibco) for 5 min at RT. A premix of PEI 25K 
transfection reagent solution (Polysciences Inc) (30 µl incubated with 250 µl of Opti-MEM for 5 min 
at RT) was then added and incubated for a further 10 min at RT. The transfection solution was placed 
on top of the 5 ml of culture medium present in the cell culture dish. Cells were harvested after overnight 
incubation. 
Isolation of detergent-free cell lysate. Cells were washed twice with PBS and scraped in 400 µl of 
detergent-free lysis buffer (10 mM Tris pH 7.5, 250 mM sucrose, 1 mM EDTA, 1 mM MgOAc, 20 µM 
ATP + Complete protease and PhosSTOP phosphatase inhibitor tablets, Roche) at +4oC. Cell extracts 
were passed through a syringe needle (0.5 mm) five times, sonicated at +4oC for 5 min and 
ultracentrifuged at 100000 x g for 1 hr at +4oC. The resulting supernatant, depleted of membrane and 
transmembrane fractions, was used for the experiment. 
Co-immunoprecipitation. An equimolar mixture of Fos-ȕ DQG -XQ-Į ZHUH VXEMHFWHG WR
immunoprecipitation using 1 Pg of the indicated antibodies at +4°C for 2 hr in 50 mM Tris pH 7.5, 150 
mM NaCl, 600 µM TCEP + 0.1% DDM. Immunoprecipitated complexes were isolated on protein-G 
beads (GE Healthcare) for 2(?hr at +4°C. Beads were then washed once with the same buffer and 
suspended into loading buffer. Samples were separated by SDS±PAGE and analysed using Western 
blotting. 
Flotation assay. Equimolar amounts of Fos-ȕDQG-XQ-ĮZHUHUHFRQVWLWXWHGLQOLSRVRPHVPL[HGLQ
1:1 ratio with a 60% sucrose solution and added to the bottom of an ultracentrifuge tube. Decreasing 
concentrations of sucrose were progressively layered on top to form a gradient and the sample was 
centrifuged overnight at 20000 x g. Fractions were retrieved and analysed by SDS-PAGE. 
Calculation of EGFP concentration within cell lysates. The fluorescence intensity of serial dilutions 
of fluorescein (1 nM ± 256 nM in dH2O) was measured using the BioTek Synergy H1 hybrid reader to 
obtain a standard curve. The fluorescence intensity of cell lysates was measured in relation to this 
standard curve and EGFP-tagged protein concentration calculated using equation (1). Fluorescein 
quantum yield in dH2O (%?Ext) and extinction coefficient (ԪExt) are 0.76 and 76900 M-1cm-1, respectively 
(Song et al., 2000; Zhang et al., 2014); GFP quantum yield (%?GFP) and extinction coefficient (ԪGFP) are 
0.53 and 70000 M-1cm-1 (for dimeric GFP) (Thermo Scientific), respectively. For EGFP-tagged 
proteins, extinction coefficients were calculated using the ExPASy ProtParam tool at 
http://web.expasy.org/protparam/ to obtain the predicted coefficient for each EGFP-tagged construct. 
The fluorescence intensity or number of excited molecules during passage of light through a sample 

































   
 
 
ܫ ൌ ܫ଴݁ି୪୬ሺଵ଴ሻఌഊ௖௟ 
where ሺܫሻ corresponds to the transmitted light through the sample, ሺܫ଴ሻ is the incident radiation, ሺߝఒሻ is 
the extinction coefficient at the excited wavelength ሺߣሻ, ሺܿሻ is the concentration, and ሺ݈ሻ is the light 
path length. For low absorbance values, this can be expanded to: ܫ ൌ ܫ଴ሾ⁡? െሺ⁡?⁡?ሻߝఒ݈ܿሿ 
The emission intensity ሺܨఒሻ for one type of molecule at a given wavelength is a function of the quantum 
yield ሺ߶ிሻ, the fraction of emission that occurs at that wavelength ሺ ఒ݂ሻ, and the fraction of the radiation 
that is actually collected by the detector ሺ݆ሻ:  ܨఒ ൌ ሺ⁡?⁡?ሻߝఒ݈ܿܫ଴߶ி ఒ݂݆ 
Solving this equation for the concentration of our EGFP-labelled molecule we obtain the following 
expression (sub-indices indicate the sample):  
ܿீி௉ ൌ ீܨ ி௉ሺ⁡?⁡?ሻߝீி௉݈ܫ଴߶ீி௉ ఒ݂݆ 
Now using the calibration curve obtained with external standard we can obtain the incident radiation ሺܫ଴ሻ: ܫ଴ ൌ ܨா௫௧ሺ⁡?⁡?ሻߝா௫௧݈ܿா௫௧߶ா௫௧ ఒ݂݆ 
that when combined with the previous equation results in equation (1):   
 ܿீி௉ ൌ ீܨ ி௉ߝா௫௧ܿா௫௧߶ா௫௧ߝீி௉߶ீி௉ܨா௫௧  
where the ratio ܿா௫௧ ܨா௫௧ൗ  is the inverse of the slope in the linear fit of  ܨா௫௧ as a function of ܿா௫௧ in the 
calibration curve. 
Flow cytometry-based binding assay. The fluorescence of cell lysate (excitation/emission, 485/528) 
was measured in relation to a fluorescein titration curve in dH2O using the BioTek Synergy H1 hybrid 
reader. Equation (1) was applied to calculate the actual EGFP-tagged protein concentration. The 
concentration of cell lysate was adjusted by dilution in detergent-free reconstitution buffer (50 mM Tris 
S+P01D&ODQGȝ07&(3ȝO&HOOO\VDWHZDVWUDnsferred to an Eppendorf tube and 
incubated with 90 µl of reconstitution buffer (50 mM Tris pH 7.0, 150 mM NaCl and 600 µM TCEP) 







































   
 
 
Samples were then incubated with SA-beads (2 µl) for 30 min at +4oC. Samples were kept on ice and 
loaded one at a time on a %'/65)RUWHVVDFHOODQDO\]HU%'%LRVFLHQFH. 
Flow cytometry settings, data acquisition and analysis 
Data acquisition was performed with a fluorescence-activated cell sorter (FACS) /65)RUWHVVDIORZ
cytometer (BD Biosciences) and the dedicated BD FACSDivaTM software. 
To excite and detect liposome-bound EGFP fluorescence emission (excitation/emission, 488/509) a 488 
nm laser line together with a filter set of a 505 nm long-pass filter and a 530/30 nm filter was used. To 
detect Cy5 (excitation/emission, 496,565/670) 532 nm laser line together with a filter set of a 635 nm 
long-pass filter and a 670/30 nm filter was used.  
Before any measurements were made, voltages in the photomultiplier tube (PMT) were adjusted 
accordingly to make streptavidin bead population fit into the linear range of the instrument as visually 
evaluated by scatter plot (FSC-A vs. SSC-A, Fig. 1c).  
Subsequently, PMT was adjusted to accommodate both background fluorescence from the beads and 
sample fluorescence into the detection window. The typical count rate was below 200 events/second.  
Raw data was analysed by using a non-commercial Flowing Software ver. 2.5 (Mr Perttu Terho; Turku 
Centre for Biotechnology, Finland; www.flowingsoftware.com), where the appropriate population of 
beads was gated and analysed for their respective fluorescence intensities. Median fluorescence values 
were used for the subsequent data analysis as these are less sensitive for outliers than mean values. 
 
KD fitting for EGFP-tagged proteins isolated from cell lysates. To obtain minimal background, 
synthetic POPC was used for KD measurement instead of EggPC. Liposomes containing synthetic 
POPC lipids (80.5% w/w), cholesterol (15% w/w), biotinylated lipid (2% w/w) and PI(3,4,5)P3 (2.5% 
w/w) (for BTK-PH-EGFP) or PI(3)P (2.5 % w/w) (for tandem FYVE-EGFP) were prepared as before. 
In control liposomes, used to measure background fluorescence resulting from non-specific binding 
events, POPC concentration was increased (83% w/w) to compensate for the absence of 
phosphoinositides. Cells expressing EGFP-tagged proteins were lysed and EGFP-tagged protein 
concentration was determined as described using equation (1). Serial dilutions of the EGFP-tagged 
proteins were then prepared and incubated with PI-containing or control liposomes. EGFP-tagged 
protein binding to liposomes was measured by flow cytometry and background fluorescence was 
subtracted. The theoretical maximum fluorescence (Fmax) value was estimated by curve fitting: 
 ܨ ൌ ܨ௠௔௫ሾܲሿሾܲሿ ൅ ܭ஽ 
Where F is the raw background-subtracted fluorescence value and [P] is protein concentration. Raw 





































ߠ ൌ ܨܨ௠௔௫ ൌ ሾ ௕ܲ௢௨௡ௗ@ሾܲܫ ௧ܲ௢௧௔௟@ 
 
where [Pbound] is the concentration of the protein bound to PIP and [PIPtotal] is the total concentration of 
PIP at the vesicle. Finally, KD was calculated from equation:  
ߠ ൌ  ሾܲ@ሾܲሿ ൅ ܭ஽ 
KD fitting for recombinant His-tagged talin FERM. The His-tagged talin FERM construct and its 
purification have been described elsewhere (Elliott et al., 2010). For use in ProLIF, recombinant His-
tagged talin FERM was first labelled with Alexa-Fluor488-Maleimide (dye:protein ratio 1:10) 
overnight in 50 mM Tris pH 7.0, 150 mM NaCl, 600 µM TCEP and then dialysed overnight  in 50 mM 
Tris pH 7.4, 150 mM NaCl, 600 µM TCEP. Binding to ɴ1-integrin-containing proteoliposomes was 
measured after 2 hr of incubation with the proteoliposomes at room temperature. For the fitting of the 
data, non-specific binding to control liposomes was first subtracted and the theoretical maximum 
fluorescence (Fmax) value was estimated in order to determine occupancy.  
2FFXSDQF\ZDVWKHQSORWWHGDVDIXQFWLRQRIFRQFHQWUDWLRQDQGWKLVZDVILWWHGDJDLQVW+LOO¶VHTuation: 
ߠ ൌ  ሾܲሿ௛ሺܭ஽௛ ൅ ሾܲሿ௛ሻ 
Where [P] is protein concentration and h is +LOO¶VFRHIILFLHQWZKLFKLQWKHFDVHRIEHVWILWZDV. 
Statistical analysis 
No statistical method was used to predetermine sample size. Unless stated otherwise all experiments 
were repeated 3 or more times for data where representative images are shown and for others sufficient 
sample size was chosen to reach statistical significance. Statistical significance was determined using 
WKH 6WXGHQW¶V W-test (unpaired, two-tailed, unequal variance). N numbers are indicated in the figure 
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Figure 1. ProLIF is a flow-cytometry based assay for detection of specific protein-lipid 
interactions 
a: Outline of ProLIF workflow. Step 1: Bio-BeadsTM are added to lipids solubilized in Triton X-100 to 
remove the detergent and obtain liposomes. Step 2: liposomes are incubated with membrane-free cell 
extract containing the EGFP-tagged protein of interest. Step 3: Sepharose streptavidin beads are added 
in order to capture the liposomes via interaction with biotinylated lipids present in the liposome 
membrane. Step 4:  streptavidin beads are analysed by flow cytometry (FACS). Red dots and blue dots 
represent biotinylated lipids and PIs, respectively. Green fragments represent EGFP-tagged proteins 
from the cell lysate. 
b: Biotinylated-lipid-containing liposomes were generated with and without encapsulated Cy5-dye, 
captured on SA-beads in the presence or absence of increasing amounts of free biotin and analysed 
using FACS. Molar ratio between biotinylated lipids and soluble biotin added in each sample is 
indicated (n = 1). 
c: Scatter plot and fluorescence histograms from SA-beads alone incubated with cell lysate from EGFP 
transfected cells and analysed by FACS.  
d: SA-beads coupled to biotinylated-lipid-containing liposomes, with the indicated PI content, were 
incubated with cell lysate from EGFP alone or BTK-PH-EGFP transfected cells (equal EGFP 
concentrations) and analysed by FACS. Shown are representative dot blots, and size gating in FACS, 
and histograms depicting EGFP fluorescence intensity (FL1) profiles (note that the Axis labels are as 
in c). The red population in the scatter plot was gated for quantification. Data shown represent three 
individual experiments. 
e: Binding of BTK-PH-EGFP domain (from cell lysate as in d) to biotinylated-lipid-containing 
liposomes, with the indicated PI content, relative to control PI-free liposomes (data are normalised 
median fluorescence intensities ± SEM; n = 5 independent experiments, **p < 0.01, *** p < 0.001). 
f: Binding of EGFP-tagged PLC-PH domain (from cell lysate) to biotinylated-lipid-containing 
liposomes, with the indicated PI content, relative to control PI-free liposomes (data are normalised 
median fluorescence intensities ± SEM; n = 5 independent experiments, **p < 0.01, *** p < 0.001). 
g: Binding of tandem FYVE-EGFP domains (from cell lysate) to biotinylated-lipid-containing 
liposomes, with the indicated PI content, relative to PI-free liposomes (data are normalised median 







































Figure 2. Quantitative measurements of protein-lipid interaction with ProLIF 
a: Comparison of GFP and fluorescein standard curves. The fluorescence intensities of the indicated 
concentrations of fluorescein and recombinant GFP were determined experimentally (exp) and used to 
generate standard curves. The fluorescein standard curve was then used to calculate (calc) the theoretical 
GFP standard curve using equation (1).  
b: Titration curve of BTK-PH-EGFP binding to PI(3,4,5)P3-containing liposomes (n = 2). Cell lysates 
from BTK-PH-EGFP transfected cells were diluted to contain the indicated concentrations of the EGFP-
tagged protein (calculated as in Fig. 2a using equation (1)) and incubated with the liposomes. Protein-
liposome interactions were subsequently analysed by FACS as outlined by the workflow in Fig. 1a. 
c: Titration curve of tandem FYVE EGFP binding to PI(3)P-containing liposomes (n = 2). Cell lysates 
from tandem FYVE EGFP transfected cells were diluted to contain the indicated concentrations of the 
EGFP-tagged protein (calculated as in Fig. 2a using equation (1)) and incubated with the liposomes. 








































Figure 3. Reconstituting integrin transmembrane-cytoplasmic domains on liposomes 
a: Domain architecture of MBP-Jun-ĮDQG*67-Fos-ȕFRQVWUXFWV*JO\FLQH70'WUDQVPHPEUDQH
domain; CT: cytoplasmic domain; Cys: cysteine.  
b: The indicated purified recombinant proteins alone or in combination were subjected to 
immunoprecipitation with an anti-ȕ LQWHJULQ DQWLERG\GLUHFWHG DJDLQVW WKHȕ F\WRSODVPLFGRPDLQ
MBP-Jun-ĮFo-immunoprecipitated with GST-Fos-ȕ)LOWHUVZHUHSUREHGZLWKUDEELWDQWL-ĮLQWHJULQ
cytoplasmic domain antibody and then reprobed with rabbit anti-ȕ LQWHJULQ F\WRSODVPLF GRPDLQ
DQWLERG\ $UURZ LQGLFDWHV WKH ȕ-integrin chimera band. Representative blot is shown. (n = 2 

































   
 
 
c: The indicated purified recombinant proteins alone or in combination were subjected to 
LPPXQRSUHFLSLWDWLRQZLWKDQ DQWLĮ LQWHJULQDQWLERG\GLUHFWHG DJDLQVW WKHĮ cytoplasmic domain: 
GST-Fos-ȕFo-immunoprecipitated with MBP-Jun-Į. Filters were probed with rabbit anti-ȕLQWHJULQ
cytoplasmic domain antibody and then reprobed with rabbit anti-Į LQWHJULQ F\WRSODVPLF GRPDLQ
DQWLERG\ $UURZ LQGLFDWHV WKH Į-integrin chimera band. Representative blot is shown. (n = 2 
independent experiments).  
d: Schematic of MBP-Jun-ĮDQG*67-Fos-ȕLQWHJULQLQFRUSRUDWLRQLQSURWHROLSRVRPHV.  
e: Gradient flotation assay showing reconstitution of GST-Fos-ȕ 0%3-Jun-Į DQG WKH ȕĮ
heterodimer in liposomes. Purified recombinant GST-Fos-ȕDQG0%3-Jun-ĮZHUHLQFRUSRUDWHGHLWKHU
alone or in combination into liposomes as depicted in 3d. The resulting proteoliposomes were analysed 
using a flotation assay in sucrose gradient. Liposome-incorporated-proteins float up the gradient (10-
20% sucrose fractions), whereas in the absence of liposomes the protein alone remains in the bottom 
(30% sucrose) fraction (GST-Fos-ȕ LQ WKHPRVW ULJKWKDQGSDQHO The protein:lipid molar ratio is 








































Figure 4. PIP2 and PIP3 synergize with integrin E1-tail to support talin-head recruitment 
a: Example fluorescence intensity histograms of Talin FERM-EGFP (from lysates of transfected cells) 
binding to biotinylated-lipid-containing proteoliposomes, with PI(4,5)P2 and GST-Fos-ȕ integrin as 


































   
 
 
b: Quantification of binding of Talin FERM-EGFP and EGFP control cell lysates at equimolar 
concentration to proteoliposomes with the indicated PI and integrin content (data are normalised median 
fluorescence intensities ± SEM; n = 6 independent experiments n.s. not significant, *** p < 0.001, **** 
p < 0.0001). 
c: Example fluorescence intensity histograms of Talin FERM-EGFP (from lysates of transfected cells) 
binding to biotinylated-lipid-containing proteoliposomes, with PI(4,5)P2, PI(3,4,5)P3 and GST-Fos-ȕ
integrin as indicated. Grey, lipids control (no PI); red, GST-Fos-ȕ; yellow, PI(4,5)P2 + GST-Fos-ȕ; 
green, PI(3,4,5)P3 + GST-Fos-ȕ  
d: Quantification of binding of Talin FERM-EGFP to proteoliposomes with the indicated PI and 
integrin content. (data are normalised median fluorescence intensities ± SEM; n = 6 independent 
experiments *p < 0.05, **p < 0.01, *** p < 0.001, **** p < 0.0001). 
e: Titration curve of recombinant His-tagged talin-FERM (labelled with Alexa-Fluor488-Maleimide) 
binding to GST-Fos-ɴ1 integrin-containing proteoliposomes (n = 2). Recombinant protein was diluted 
to contain the indicated concentrations and incubated with the proteoliposomes and interactions were 





































































Supplementary Figure 1  
a: Detection of SA-beads by flow cytometry. 1/1000 of the events typically detected in one sample are 
shown.  
b: Scatter plots resulting from biotinylated-liposomes bound to SA-beads by flow cytometry. 1/1000 
of the events typically detected in one sample are shown.  
c: Western blot analysis of the isolated detergent-free cell lysate fraction used in liposome binding 
assays compared to the Triton X-100-solubilizHG IUDFWLRQ ULFK LQ WUDQVPHPEUDQH ȕ LQWHJULQ DQG
membrane associated proteins (Rab21). Uncropped blots can be found in Figure S6. 
d: Titration curve with decreasing amounts of PLC-PH-EGFP (n = 1). Cell lysates from PLC-PH-
EGFP transfected cells were diluted to contain the indicated concentrations of the protein (calculated 
based on equation (1)), incubated with liposomes with and without PI(4,5)P2 and analyzed for protein-
liposome binding using FACS.  



































Supplementary Figure 2  
a: Overlay of fluorescence intensity histograms of EGFP and BTK-PH-EGFP bound to different PI 
species (individual histograms shown in Fig. 1d).  
b: Representative  scatter plots, fluorescence intensity histograms and histogram overlays (from 
experiments quantified in Fig. 1f) of PLC-PH-EGFP bound to different PI species. The red population 
in the scatter plot was gated for quantification. 



































Supplementary Figure 3 
a,b: Sequential steps in GST-Fos-ȕ (a) and MBP-Jun-Į (b) purification. Shown are coomassie-
stained SDS-PAGE gels loaded with the following samples: #1, whole lysate after cell disruption; #2, 
supernatant from low-speed centrifugation; #3, supernatant from high-speed centrifugation; #4, 
resuspended membrane pellet from high-speed centrifugation; #5, resuspended membrane pellet after 
solubilisation in DDM; #6 supernatant from high-speed centrifugation; #7, flow-through from Ni2+ 
matrix; #8, eluted from Ni2+ matrix; #9, flow-through from glutathione or amylose matrix; #10, 
eluted from glutathione or amylose matrix; #11, protein stored after dialysis. 
c: Titration curve with decreasing amount of Talin FERM-EGFP (n = 1). Cell lysates from Talin 
FERM-EGFP transfected cells were diluted to contain the indicated concentrations of the protein 
(calculated using equation (1)), incubated with liposomes with and without GST-Fos-ȕand analyzed 
for protein-liposome binding using flow cytometry.  



































Supplementary Figure 4  
a: Representative flow cytometry FSC-A vs SSC-A and FSC-A vs FSC-W scatter plots of SA-beads 
for all Talin FERM-EGFP samples shown in Fig.4b. The red population was gated for quantification. 
b: ProLIF assay monitoring Talin FERM-EGFP (3nM; cell lysate) binding to proteoliposomes 
containing GST-Fos-ȕ and/or MBP-Jun-Į at a lower (compared to Fig. 4b) protein:lipid molar ratio 
of 1:7000 (n = 1).  
c: Competition of Talin FERM-EGFP binding to proteoliposomes by addition of soluble biotin. 
Biotinylated-lipid-containing liposomes (containing GST-Fos-ȕ and PI(4,5)P2 as indicated) were 
incubated with Talin FERM-EGFP-containing cell lysate and captured on SA-beads in the presence or 
absence of free biotin and analyzed using FACS. Molar ratio between biotinylated lipids and soluble 
biotin is 1:50 (n = 1). 
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